Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment

International Journal of Drug Policy

Volumn 25, Issue 1, 2014, Pages 22-25

  Bruce, R Douglas ^a,b,f   Lambdin, Barrot ^b,g   Chang, Olivia ^b   Masao, Frank ^c,d   Mbwambo, Jessie ^c,d   Mteza, Ibrahim ^c   Nyandindi, Cassian ^c,d   Zamudio Haas, Sophia ^e   Buma, Deus ^c,d   Dunbar, Megan S ^b   Kilonzo, Gad ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pangaea Global AIDS Foundation   (United States)

^c MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f YALE UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HIV; Integrated care; Methadone; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; METHADONE; TUBERCULOSTATIC AGENT;

AMBULATORY CARE; DIRECTLY OBSERVED THERAPY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; INTRAVENOUS DRUG ABUSE; MEDICATION COMPLIANCE; METHADONE TREATMENT; MORBIDITY; NOTE; OPIATE ADDICTION; PRIORITY JOURNAL; SCALE UP; TANZANIA; TUBERCULOSIS;

HIV; INTEGRATED CARE; METHADONE; TUBERCULOSIS;

DELIVERY OF HEALTH CARE, INTEGRATED; HIV INFECTIONS; HUMANS; MENTAL HEALTH SERVICES; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROGRAM DEVELOPMENT; TANZANIA; TUBERCULOSIS;

EID: 84892983183     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.09.005     Document Type: Note

References (20)

1. Baisley K., Doyle A.M., Changalucha J., Maganja K., Watson-Jones D., Hayes R., et al. Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: Comparison of opt-out and opt-in strategies. PLoS One 2012, 7:e42108.
2. Berg K.M., Litwin A., Li X., Heo M., Arnsten J.H. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence 2011, 113:192-199.
3. Bruce R.D. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy 2010, 21:122-124.
4. Bruce R.D. Report on integrated treatment for HIV-infected opioid dependent persons 2010, USAID Ukraine, Ukraine.
5. Bruce R.D., Altice F.L., Gourevitch M.N., Friedland G.H. Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice. Journal of Acquired Immune Deficiency Syndromes 2006, 41:563-572.
6. Bruce R.D., Dvoryak S., Sylla L., Altice F.L. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine - programme description and policy implications. International Journal of Drug Policy 2007, 18:326-328.
7. Bruce R.D., Eiserman J., Acosta A., Gote C., Lim J.K., Altice F.L. Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: Implications for program replication. The American Journal of Drug and Alcohol Abuse 2012, 38:206-212.
8. Getahun H., Gunneberg C., Granich R., Nunn P. HIV infection - associated tuberculosis: The epidemiology and the response. Clinical Infectious Diseases 2010, 50:S201-S207.
9. Getahun H., Gunneberg C., Sculier D., Verster A., Raviglione M. Tuberculosis and HIV in people who inject drugs: Evidence for action for tuberculosis, HIV, prison and harm reduction services. Current Opinion in HIV and AIDS 2012, 7:345-353.
10. Gupta A., Mbwambo J., Bruce R.D. Active case finding for tuberculosis among injection drug users in medication-assisted treatment in Dar es Salaam, Tanzania. Infectious disease society of America's ID week 2012.
11. Martín V., Caylà J.A., Bolea Á., Castilla J. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. The International Journal of Tuberculosis and Lung Disease 2000, 4:41-46.
12. Lambdin B., Mbwambo J., Bruce R.D., Masao F., Nyandindi C., Ivo Y., et al. Evaluating enrollment and retention of people who inject drugs in the medication assisted treatment cascade in Dar es Salaam, Tanzania. International AIDS conference 2012, THPE720.
13. Lambdin B.H., Bruce R.D., Chang O., Nyandindi C., Sabuni N., et al. Identifying programmatic gaps: Inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLoS ONE 2013, 8:e67062.
14. Lucas G.M., Mullen B.A., Weidle P.J., Hader S., McCaul M.E., Moore R.D. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases 2006, 42:1628-1635.
15. McCurdy S.A., Williams M.L., Kilonzo G.P., Ross M.W., Leshabari M.T. Heroin and HIV risk in Dar es Salaam, Tanzania: Youth hangouts, mageto and injecting practices. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV 2005, 17:S65-S76.
16. Pérez-Perdomo R.P.-C.C. An epidemiological review of tuberculosis in the Puerto Rican population. Puerto Rico Health Sciences 1999, 18:117-122.
17. Sylla L., Bruce R.D., Kamarulzaman A., Altice F.L. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy 2007, 18:306-312.
18. UNAIDS United Republic of Tanzania HIV and AIDS estimates 2009, UNAIDS, Geneva.
19. WHO Global Tuberculosis Control 2011, World Health Organization, Geneva, Switzerland.
20. Williams M.L., McCurdy S.A., Bowen A.M., Kilonzo G.P., Atkinson J.S., Ross M.W., et al. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Education and Prevention 2009, 21:474-483.